|
Sr. Medical Science Liaison, AIR - Southeast
|
Cary, NC, US
|
4 avr. 2025
|
5315
|
|
|
Sr. Medical Science Liaison, AIR - Central
|
Cary, NC, US
|
4 avr. 2025
|
5316
|
|
|
Sr. Manager, Forecasting
|
Cary, NC, US
|
27 mars 2025
|
5128
|
|
|
Sr. Field Reimbursement Manager, Global Rare Diseases - Central
|
Chicago, IL, US
|
3 avr. 2025
|
5469
|
|
|
Senior Medical Science Liaison - AIR, West
|
Las Vegas, NV, US
|
10 avr. 2025
|
4623
|
|
|
Real World Evidence, Contractor
|
Cary, NC, US
|
18 avr. 2025
|
5195
|
|
|
Rare Disease Marketing Lead
|
Remote role based in the UK, GB
|
10 avr. 2025
|
5519
|
|
|
Project Coordinator Rare Diseases
|
Amsterdam or Brussels, NL
|
10 avr. 2025
|
5198
|
|
|
Project Coordinator - Brand Execution
|
Cary, NC, US
|
5 avr. 2025
|
5318
|
|
|
Product Manager
|
warszawa, PL
|
29 mars 2025
|
5289
|
|
|
Omnichannel Marketing Partner - Cardiovascular
|
Cary, NC, US
|
19 avr. 2025
|
5404
|
|
|
Omnichannel Manager
|
Manchester, GB
|
11 avr. 2025
|
5531
|
|
|
Medical Systems and Processes Lead, Global Rare Diseases (Contract)
|
Boston, MA, US
|
8 avr. 2025
|
5477
|
|
|
Medical Science Liaisons Manager
|
Torun, PL
|
19 avr. 2025
|
1557
|
|
|
Medical Science Liaison - Respiratory (up to 12 months FTC)
|
Manchester, GB
|
11 avr. 2025
|
5429
|
|
|
Marketing Trainee Special Care
|
Barcelona, ES
|
18 avr. 2025
|
5202
|
|
|
Marketing Solution Partner
|
Barcelona, ES
|
12 avr. 2025
|
5072
|
|
|
Lead, Field Medical Team - AIR, US West
|
Cary, NC, US
|
9 avr. 2025
|
5165
|
|
|
Lead, Field Medical Team - AIR, US East
|
Cary, NC, US
|
9 avr. 2025
|
5166
|
|
|
Insights & Analytics Manager
|
Cary, NC, US
|
4 avr. 2025
|
5311
|
|
|
Head of Real World Evidence, US
|
Cary, NC, US
|
27 mars 2025
|
5252
|
|
|
Head of MSL, NL
|
Amsterdam, NL
|
19 avr. 2025
|
5367
|
|
|
Head of Medical Strategic Operations, Global Rare Diseases
|
Boston, MA, US
|
1 avr. 2025
|
5470
|
|
|
Global Senior Manager, Medical Information
|
Boston, MA, US
|
16 avr. 2025
|
5544
|
|
|
Global Patient Demand Forecasting Lead
|
Parma, IT
|
29 mars 2025
|
5140
|
|
